Innovation in rheumatology at EULAR 2025

EULAR 2025 stands as a cornerstone of the rheumatology calendar – a unifying platform where people living with rheumatic diseases, healthcare professionals, and industry partners come together to share, learn, and advance care. It is here that the latest scientific discoveries are brought into focus, so they can be explored through shared learning and ultimately translated into meaningful change for patients.

At the core of UCB’s approach is innovation – a concept that reflects our ambition to use trailblazing science to deliver value for people living with immune-mediated inflammatory diseases. In rheumatology, this means going beyond symptomatic relief to pursue long-term disease control and functional improvement. In psoriatic arthritis, for example, we know that uncontrolled active disease can lead to irreversible damage.

Too often, innovation is treated simply as an endpoint. But in chronic, immune-mediated diseases, its true value lies in how it performs over time and responds to the evolving needs of people living with disease. This includes exploring how digital tools can support earlier diagnosis and more tailored disease monitoring – taking an approach to innovation that is not only scientifically rigorous, but also responsive to the real-world needs of people living with these conditions. At UCB, our goal is to build a differentiated and evolving portfolio to help people live a better quality of life and reduce disease progression through scientific advancement that lasts.

With 19 scientific abstracts at EULAR 2025, across psoriatic arthritis, axial spondyloarthritis, systemic lupus erythematosus, and osteoporosis, we are proud to contribute a diverse and robust body of science across our immunology portfolio. These data reflect our broad commitment to uncover deep clinical insight across multiple immune-mediated conditions, including our understanding of how these conditions may be linked through inflammatory pathways. Each presentation, each discussion, and each insight shared at EULAR reinforces our belief that continuous innovation is essential to shaping a better standard of care.  

As a physician, I understand the importance of long-term solutions for people living with chronic diseases. It takes continuous innovation to develop differentiated solutions that last. When it comes to improving lives, progress is not a one-off. It is a long-term promise – one we are committed to fulfilling through innovation.